Author

Thomas Jacobsen

North Carolina State UniversityPrimary ORCID profile (0000-0002-1523-3996 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Thomas JacobseniD1 paper · University of Jyväskylä

Biology Disciplines

Click to filter author papers

Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:CRISPR screen· 1 Organism:E. coli· 1 Approach:experimental assay· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Anna Singer· 1 shared Benjamin N. Gray· 1 shared Chase L. BeiseliD· 1 shared Colin S. MaxwelliD· 1 shared Emma January· 1 shared Matthew B. BegemanniD· 1 shared Michelle L. Luo· 1 shared Ryan Marshall· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Anna Singer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rapid and scalable characterization of CRISPR technologies using an E. coli cell-free transcription-translation system

Ryan Marshall, Colin S. Maxwell, Scott P. Collins, Thomas Jacobsen, Michelle L. Luo, Matthew B. Begemann, Benjamin N. Gray, Emma January, Anna Singer, Yonghua He, Chase L. Beisel, Vincent Noireaux

This paper introduces an E. coli cell-free system to rapidly and scalably characterize CRISPR technologies, including DNA cleavage, gene repression, and anti-CRISPR activity.

Molecular Cell · Jan 1, 2018Peer-reviewedSynthetic Biology